Bienvenue sur le site de l'université Paris Descartes

mai 2013

  • 24 maiMyeloid derived suppressor cells their role and regulation in cancer

    24 mai 2013
    Séminaires/Colloques

    François GHIRINGHELLI

    Head of Team 1 INSERM 866 "Chemotherapy, lipid metabolim and immune response"
     Full Professor of Oncology, University of Burgundy, Department odf Medical Oncology, Dijon

     

                                          Invité par Catherine Sautès-Fridman

     

     « Myeloid derived suppressor cells their role and regulation in cancer »

     

     

    Myeloid-Derived Suppressor Cells (MDSC) are a population of immature myeloid cells, which could suppress T dependent immune response. MDSC numbers increase inblood and lymphoid organ of mice and human bearing tumor. Thus, a cytotoxic drug that electively eliminates MDSC while preserving T cells subset may enhance latent tumor immunity and tumor vaccine efficacy. In a recent work we describe the capacity of 5-Fluorouracil (5-FU) to eliminate MDSC. However we have also discovered that the 5FU-driven activation of the NLRP3 inflammasome in MDSCs promotes tumor angiogenesis by eliciting TH17 responses that compromise anticancer immunity. This underscores the need to combine 5-FU with NLRP3 inhibitors to prevent tumor progression.

     

    Tous les séminaires du Centre de Recherche des Cordeliers  se situe dans l'amphithéâtre BILSKI-PASQUIER à 12h00 au 15 rue de l'école de médecine, 75006 Paris

    Retrouvez le programme de mai des Séminaires du CRC